Yüklüyor......
Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)
The backbone of first-line treatment for Epidermal Growth Factor (EGFR) wild-type (wt) advanced Non-small cell lung cancer (NSCLC) patients is the use of a platinum-based chemotherapy combination. The treatment is characterized by great inter-individual variability in outcome. Molecular predictive m...
Kaydedildi:
Yayımlandı: | Transl Lung Cancer Res |
---|---|
Yazar: | |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
Pioneer Bioscience Publishing Company
2013
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367600/ https://ncbi.nlm.nih.gov/pubmed/25806229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.03.07 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|